Magnetoencephalography (MEG) technology firm Megin has received an order from Arkansas Children's Hospital for its Triux neo MEG system for functional brain imaging.
MEG measures magnetic activity generated by neurons in the brain to diagnose and assess neurological abnormalities and disorders such as epilepsy, tumors, traumatic brain injury, post-traumatic stress disorder, and autism.
The 336-bed Little Rock facility houses a pediatric level I trauma center, burn center, level IV neonatal and pediatric intensive care unit, and a research institute.
Megin was formerly owned by radiation oncology vendor Elekta. U.K. MEG technology developer York Instruments purchased Megin from Elekta this past July.
